NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market Tuesday that it has signed a definitive agreement to acquire Prodesse for at least $60 million in cash.

Gen-Probe said that the acquisition price for the privately held molecular diagnostics firm could rise to up to $85 million if certain financial and regulatory milestones are met in 2010 and 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.